中文
| Catalogue |
| Recommend Products |
Company News
- EKF to Showcase POCT Connectivity Solutions at MEDICA 2022 11/2/2022
- EKF Introduces Hand-held Hemoglobin Analyzer with Secure POC Connectivity 10/19/2022
- EKF to Highlight Specific Glycemic Control Marker at AACC 2022 7/1/2022
- EKF Launches Middleware Connectivity Solution for POC Analyzers and Data Management 6/1/2022
- EKF Diagnostics Acquires ADL Health Molecular Diagnostic Testing Laboratory 11/12/2021
- EKF Diagnostics to Showcase at Medica 2021 STAT-Site® WB β-ketone and Glucose Handhel... 10/22/2021
- EKF Diagnostics to Showcase New Handheld β-ketone and Glucose Analyzer at AACC 2021 9/17/2021
- EKF Globally Launches STAT-Site® WB β-ketone and Glucose Handheld Analyzer 3/12/2021
- EKF Opens Larger Facility to Increase Production of Key Component for COVID-19 Testing Reg... 1/22/2021
- EKF Launches PrimeStore® MTM Pathogenic Sample Collection and Transportation Kit 10/27/2020
- PrimeStore® MTM Novel Viral Transport Media Successfully Evaluated by Public Hea... 9/30/2020
- EKF Introduces Novel Molecular Transport Media for Dual COVID-19 and Influenza Sampling 7/15/2020
- EKF Opens for Live Chats at ENDO Online 2020 6/11/2020
- EKF Secures COVID-19 Novel Sample Collection Kit Manufacturing and Supply Contracts 5/22/2020
- EKF & Tosoh Europe N.V. Distribution Agreement Expands HbA1c POC Testing Reach in Middle E... 5/15/2020
- EKF Launches FDA CLIA-waived β-ketone and Glucose POC Analyzer to U.S. Market 3/13/2020
- EKF Diagnostics has Opened a New Research & Development Facility at its Headquarters 2/13/2020
- EKF Diagnostics Supporting Reduction of Anemia in Developing Regions in South America 1/29/2020
- EKF Diagnostics Opens New R&D Facility in UK 9/27/2019
- EKF to Highlight Lucica® Glycated Albumin-L Assay at AACC 2019 7/26/2019